Alternative structural projections:
For other salt forms or metabolites please inquire. Fluorescent cGMP analogue (λexc 494 nm, λem 517 nm). A similar compound has been described to be the most potent channel activator tested so far: Tanaka et al., Biochemistry, 28, 2776 - 2784 (1989). Detailed technical information available. References: Pena & Dominquez, J. biol. Screen., 15, 1281 - 1286 (2010); Lolicato et al., J. Biol. Chem., 286, 44811 - 44820 (2011).
| Cat. No. | F 001 |
| CAS number | [pending] |
| Purity | > 95% HPLC |
| Salt form | Sodium |
| Storage temperature | -20°C / -4°F |
| Light-sensitive | True |
| Molecular formula | C₃₃H₂₇N₇O₁₂PS₂ · Na |
| Molecular weight [g/mol] | 831.7 |
| Modifications | 8-cGMP |
| Target | PKG (cGK) Activator |
| Excitation max [nm] | 494 |
| Emission max [nm] | 517 |
| Lipophilicity | 2.41 |
| Absorption max [nm] | ~494 |
| Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] | ~79000 |
| UV pH value | 9 |
- 1. Lolicato M., Nardini M., Gazzarrini S., Möller S., Bertinetti D., Herberg F. W., Bolognes M., Martin H., Fasolini M., Bertrand J. A., Arrigoni C., Thiel G.Moroni A., J. Biol. Chem., 286, 44811 - 44820 (2011), "Tetramerization Dynamics of C-terminal Domain Underlies Isoform-specific cAMP Gating in Hyperpolarization-activated Cyclic Nucleotide-gated Channels"
- 2. Pena I.Dominguez J. M., J Biomol Screen., 15, 1281 - 1286 (2010), "Thermally Denatured BSA, a Surrogate Additive to Replace BSA in Buffers for High-Throughput Screening"
- 3. Brown R. L., Strassmaier T., Brady J. D.Karpen J. W., Curr. Pharmaceut. Design, 12, 3597 - 3613 (2006), "The Pharmacology of Cyclic Nucleotide-Gated Channels: Emerging from the Darkness"
- 4. Christensen A. E.Doeskeland S. O., Handbook of Cell Signaling Academic Press/Elsevier Science San Diego CA, 2, 549 - 554 (2003), "Cyclic Nucleotide Analogs as Tools to Investigate Cyclic Nucleotide Signaling"
- 5. Reymond C. D., , 0, 0 - 0 (2003), "Use of the Regulatory Subunit of the cAMP Dependent Protein Kinase (PKA) from Dictyostelium for cAMP Measurements"
- 6. Kuethe A., Maronde E., Forssmann W.-G.Stief C. G., Pharmacol. Ther., 51, 13 - 33 (2000), "Detection of cGMP-Binding Proteins in Human Corpus Cavernosum"
- 7. Scott S.-P.Tanaka J. C., Biochemistry, 34, 2338 - 2347 (1995), "Molecular Interactions of 3',5'-Cyclic Purine Analogues with the Binding Site of Retinal Rod Ion Channels"
- 8. Olson A.Pugh E. N., Biophys. J., 65, 1335 - 1352 (1993), "Diffusion Coefficient of Cyclic GMP in Salamander Rod Outer Segments Estimated with Two Fluorescent Probes"
- 9. Tanaka J. C., Eccleston J. F.Furman R. E., Biochemistry, 28, 2776 - 2784 (1989), "Photoreceptor Channel Activation by Nucleotide Derivatives"
- 10. Pusch M.Neher E., Pflugers Arch. Eur. J. Physiol., 411, 204 - 211 (1988), "Rates of Diffusional Exchange between Small Cells and a Measuring Patch Pipette"
- 11. Ruf H. H., Rack M., Landgraf W.Hofmann F., in L.M.G. Heilmeyer: Signal Transduction and Protein Phosphorylation NATO ASI Series A: Life Sciences, 135, 99 - 104 (1987), "Binding of Fluorescent Analogs of Cyclic GMP to cGMP-dependent Protein Kinase"
